Skip to main content
SpringerLink
Log in

Seneszenz und Altershypogonadismus

  • Chapter
Andrologie

Zusammenfassung

Die wachsende Überalterung der Bevölkerung und die dadurch bedingten sozialen, medizinischen und auch ökonomischen Konsequenzen in den meisten westlichen Industrienationen rücken zunehmend in den Fokus der Öffentlichkeit. So ist die mittlere Lebenserwartung in Deutschland in den letzten 100 Jahren um nahezu das Doppelte angestiegen (◘ Abb. 14.1). Diese Entwicklung geht hauptsächlich auf verbesserte Hygiene, Reduzierung der Neugeborenenmortalität und effektivere Therapie und Prophylaxe akuter Krankheiten im Erwachsenenalter zurück. Aufgrund dieser Entwicklung spielen gesundheitliche, soziale und psychologische Probleme älterer Menschen eine immer größere Rolle in Klinik und Forschung. Aber nicht nur die Lebenserwartung nimmt zu, sondern durch geänderte individuelle Lebensplanungen und wirksame Kontrazeptionsmöglichkeiten wird der Zeitpunkt der Familiengründung zunehmend in ein höheres Alter hinein verschoben, in dem die Fertilität zumindest des weiblichen Partners bereits deutlich eingeschränkt ist.

Durchschnittliche Lebenserwartung von Männern und Frauen in Deutschland bei der Geburt von 1901–2006. (Quelle: Statistische Jahrbücher 1989–2007 Statistisches Bundesamt Wiesbaden)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A (2003) The standardisation of terminology in lower urinary tractfunction: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49

    PubMed  Google Scholar 

  • Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI (2008) Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab 93:139–146

    CAS  PubMed  Google Scholar 

  • Ali ST, Shaik RN, Siddiqi NA, Siddiqi PQ (1993) Semen analysis in insulin-dependent /non-insulin-dependent diabetic men with/without neuropathy. Arch Androl 30:47–54

    CAS  PubMed  Google Scholar 

  • Amin S, Zhang Y, Felson DT, Sawin CT, Hannan MT, Wilson PW, Kiel DP (2006) Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 119:426–433

    CAS  PubMed  Google Scholar 

  • Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN, Tomlinson B (2001) Factor analysis of the metabolic syndrome: obesity vs. insulin resistance as the central abnormality. Int J Obesity 25:1782–1788

    CAS  Google Scholar 

  • Araujo AB, Esche GR, Kupelian V, O’Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92:4241–4247

    CAS  PubMed  Google Scholar 

  • Bachmann R, Happle R, Held KR, Holzgreve W, Kunze J, Rauskolb R, Rehder H, Sewig K-Fr, Schmidtke J, Wolff G, Wollersheim U Wissenschaftlicher Beirat der Bundesärztekammer (2007) Richtlinien zur pränatalen Diagnostik von Krankheiten und Krankheitsdisp ositionen (http://www.bundesärztekammer.de)

    Google Scholar 

  • Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE Bremner WJ (1994) Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrin Metab 79:561–567

    CAS  Google Scholar 

  • Behre HM, Bohmeyer J, Nieschlag E (1994) Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol 40:341–349

    CAS  Google Scholar 

  • Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1995–2010

    CAS  PubMed  Google Scholar 

  • Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O’Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM (2002) Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288:2282–2292

    CAS  PubMed  Google Scholar 

  • Bordson BL, Leonardo VS (1991) The appropriate upper age limit for semen donors: a review of the genetic effects of paternal age. Fertil Steril 56:397–401

    CAS  PubMed  Google Scholar 

  • Bryant J, Loveman E, Cave C, Chase D, Milne R (2002) Endocrinology trial design: adverse event reporting in randomised controlled trials of recombinant human GH in GH-deficient adults. J Endocrinol 175:545–552

    CAS  PubMed  Google Scholar 

  • Cassells HB, Haffner SM (2006) The metabolic syndrome: risk factors and management. J Cardiovasc Nurs 21:306–313

    PubMed  Google Scholar 

  • Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S (2005) Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 60:1451–1357

    PubMed  Google Scholar 

  • Colao A, Marzullo P, Ferone D, Spiezia S, Cerbone G, Marino V, Di Sarno A, Merola B, Lombardi G (1998) Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab 83:775–779

    CAS  PubMed  Google Scholar 

  • Crow JF (1997) The high spontaneous mutation rate: is it a health risk? Proc Natl Acad Sci USA 94:8380–8386

    CAS  PubMed  Google Scholar 

  • Dakouane M, Bicchieray L, Bergere M, Albert M, Vialard F, Selva J (2005) A histomorphometric and cytogenetic study of testis from men 29–102 years old. Fertil Steril 83:923–928

    PubMed  Google Scholar 

  • Delhez M, Hansenne M, Legros JJ (2003) Andropause and psychopathology: minor symptoms rather than pathological ones. Psychoneuroendocrinology 28:863–874

    CAS  PubMed  Google Scholar 

  • Dennison E, Hindmarsh P, Fall C, Kellingray S, Barker D, Phillips D, Cooper C (1999) Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab 84:3058–3063

    CAS  PubMed  Google Scholar 

  • Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD (2003) Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol 58:710–717

    CAS  Google Scholar 

  • von Eckardstein A, Wu FCW (2004) Testosterone and cardiovascular diseases in: Nieschlag E, Behre HM (eds) Testosterone: Action, Deficiency, Substitution (3rd edition), Cambridge University Press, Cambridge pp 297–332

    Google Scholar 

  • Eisenmann JC (2003) Secular trends in variables associated with the metabolic syndrome of North American children and adolescents: a review and synthesis. Am J Hum Biol 15:786–794

    PubMed  Google Scholar 

  • Elliot ML (1990) Psychological aspects of sexual dysfunction in the elderly. In: Armbrecht HJ, Coe RM, Wongsurawat N (eds) Endocrine function and age. Springer, Heidelberg, pp 136–146

    Google Scholar 

  • Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA (2006) Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91:3494–3498

    CAS  PubMed  Google Scholar 

  • Eskenazi B, Wyrobek AJ, Slotzer E, Kidd SA, Moore L, Young S, Moore D (2003) The association of age and semen quality in healthy men. Hum Reprod 18:447–454

    CAS  PubMed  Google Scholar 

  • Finkel E (1998) Telomeres: keys to senescence and cancer. Lancet 351:1186

    CAS  PubMed  Google Scholar 

  • Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, Allen S, Krause G (1999) Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 84:1527–1533

    CAS  PubMed  Google Scholar 

  • Francis RM (1999) The effects of testosterone on osteoporosis in men. Clin Endocrinol (Oxf) 50:411–414

    CAS  Google Scholar 

  • Frattarelli JL, Miller KA, Miller BT, Elkind-Hirsch K, Scott RT Jr. (2008) Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles. Fertil Steril 90:97–103

    PubMed  Google Scholar 

  • Gallardo E, Simon C, Levy M, Guanes PP, Remohi J, Pellicer A (1996) Effect of age on sperm fertility potential: oocyte donation as a model. Fertil Steril 66:260–264

    CAS  PubMed  Google Scholar 

  • Gann PH, Hennekens CH, Longcope C, Verhoek-Oftedahl W, Grodstein F, Stampfer MJ (1995) A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 26:40–49

    CAS  PubMed  Google Scholar 

  • Garfinkel D, Berner YN (1998) Antioxidants and aging: is melatonin a possible, practical new hope? Nutrition 14:712–713

    CAS  PubMed  Google Scholar 

  • Garfinkel D, Laudon M, Nof D, Zisapel N (1995) Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 346:541–544

    CAS  PubMed  Google Scholar 

  • Giovannucci E, Platz EA, Stampfer MJ, Chan A, Krithivas K, Kawachi I, Willett WC, Kantoff PW (1999) The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology 53:121–125

    CAS  PubMed  Google Scholar 

  • Gray A, Feldman HA, McKinlay JB, Longcope C (1991) Age, and changing sex hormone levels in middle-aged men: Results of the Massachusetts male aging study. J Clin Endocrinol Metab 73:1016–1025

    CAS  PubMed  Google Scholar 

  • Greendale GA, Unger JB, Rowe JW, Seeman TE (1999) The relation between cortisol excretion and fractures in healthy older people: results from the MacArthur studies-Mac. J Am Geriat Soc 47:799–803

    CAS  PubMed  Google Scholar 

  • Grimley Evans J, Malouf R, Huppert F, van Niekerk JK (2006) Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database Syst 18: BCD006221

    Google Scholar 

  • Hajjar RR, Kaiser FE, Morley JE (1997) Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 82:3793–3796

    CAS  PubMed  Google Scholar 

  • Handelsman D J, Staraj S (1985) Testicular size: the effects of aging, malnutritrion, and illness. J Androl 6:144–151

    CAS  PubMed  Google Scholar 

  • Harkonen K, Huhtaniemi I, Makinen J, Hubler D, Irjala K, Koskenvuo M, Oettel M, Raitakari O, Saad F, Pollanen P (2003) The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 26: 187–194

    CAS  PubMed  Google Scholar 

  • Harzmann R, Weckermann D, Wawroschek F (1998) Treatment of benign prostate hyperplasia. Z Ärztl Fortbild Qualitatssich 92:319–324

    CAS  PubMed  Google Scholar 

  • Hassan MA, Killick SR (203) Effect of male age on fertility, evidence for the decline in male fertility with increasing age. Fertil Steril 79:1520–1527

    Google Scholar 

  • Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, Zattoni F, European Association of Urology (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80

    PubMed  Google Scholar 

  • Hellstrom WJ, Overstreet JW, Sikka SC, Denne J, Ahuja S, Hoover AM, Sides GD, Cordell WH, Harrison LM, Whitaker JS (2006) Semen and sperm reference ranges for men 45 years of age and older. J Androl 27:421–428

    PubMed  Google Scholar 

  • Herbert J (1995) The age of dehydroepiandrosterone. Lancet 345:1193–1194

    CAS  PubMed  Google Scholar 

  • Ho KK (2007) GH Deficiency Consensus Workshop Participants Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157:695–700

    CAS  PubMed  Google Scholar 

  • Hosltein AF (1989) Morphological evidence for the involution of spermatogenesis during senescence. In: Holstein AF, Voigt KD, Grässlin D (eds) Reproductive biology and medicine. Diesbach Verlag, Berlin, pp 66–77

    Google Scholar 

  • Jenkins PJ, Mukherjee A, Shalet SM (2006) Does growth hormone cause cancer? Clin Endocrinol 64:115–121

    CAS  Google Scholar 

  • Johnson L, Grumbles JS, Bagheri A, Petty CS (1990) Increased germ cell degeneration during postprophase of meiosis is related to increased serum follicle-stimulating hormone concentrations and reduced daily sperm production in aged men. Biol Reprod 42:281–287

    CAS  PubMed  Google Scholar 

  • Kapoor D, Malkin CJ, Channer KS, Jones TH. (2005) Androgens, insulin resistance and vascular disease in men. Clin Endocrinol 63: 239–250

    CAS  Google Scholar 

  • Kapoor D, Goodwin E, Channer KS, Jones TH (2006) Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154:899–906

    CAS  PubMed  Google Scholar 

  • Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications Endocr Rev 26:833–876

    CAS  PubMed  Google Scholar 

  • Kelleher S, Conway AJ, Handelsman DJ (2004) Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 89:3813–3817

    CAS  PubMed  Google Scholar 

  • Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116: 2694–2697

    CAS  PubMed  Google Scholar 

  • Kidd SA, Eskenazi B, Wyrobek A (2001) Effects of male age on semen quality and fertility: a review of the literature. Fertil Steril 75: 237–248

    CAS  PubMed  Google Scholar 

  • Kirkwood TB (2008) Understanding ageing from an evolutionary perspective. J Intern Med 263:117–127

    CAS  PubMed  Google Scholar 

  • Kühnert B, Nieschlag E (2004) Reproductive functions of the ageing male. Hum Reprod Update 10:327–339

    PubMed  Google Scholar 

  • Krassas GE, Perros P (2003) Thyroid disease and male reproductive function. J Endocrinol Invest 26:372–380

    CAS  PubMed  Google Scholar 

  • Krithivas K, Yurgalevitch SM, Mohr BA, Wilcox CJ, Batter SJ, Brown M, Longcope C, McKinlay JB, Kantoff PW (1999) Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol 162:137–142

    CAS  PubMed  Google Scholar 

  • Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in non-obese men. J Clin Endocrinol Metab 91:843–850

    CAS  PubMed  Google Scholar 

  • Labrie F, Candas B, Dupont A, Cusan L, Gomez JL, Suburu RE, Diamond P, Levesque J, Belanger A (1999) Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. Prostate 38:83–91

    CAS  PubMed  Google Scholar 

  • Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27:1036–1041

    CAS  PubMed  Google Scholar 

  • Laughlin GA, Barrett-Connor E, Bergstrom J (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93: 68–75

    CAS  PubMed  Google Scholar 

  • Lepor H (2004) Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol 6:3–10

    Google Scholar 

  • Levitas E, Lunenfeld E, Weisz N, Friger M, Potashnik G (2007) Relationship between age and semen parameters in men with normal sperm concentration: analysis of 6022 semen samples. Andrologia 39:45–50

    CAS  PubMed  Google Scholar 

  • Liu PY, Iranmesh A, Nehra AX, Keenan DM, Veldhuis JD (2005) Mechanisms of hypoandrogenemia in healthy aging men. Endocrinol Metab Clin North Am 34:935–55

    CAS  PubMed  Google Scholar 

  • Lombardi G, Di Somma C, Rota F, Colao A (2005) Associated hormonal decline in aging: is there a role for GH therapy in aging men? J Endocrinol Invest 28:99–108

    CAS  PubMed  Google Scholar 

  • Lucia MS, Epstein JI, Goodman PJ, Darke AK, Reuter VE, Civantos F, Tangen CM, Parnes HL, Lippman SM, La Rosa FG, Kattan MW, Crawford ED, Ford LG, Coltman CA Jr, Thompson IM (2007) Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst 99:1375–1383

    CAS  PubMed  Google Scholar 

  • Luetjens CM, Rolf C, Gassner P, Werny JE, Nieschlag E (2002) Sperm aneuploidy rates in younger and older men. Hum Reprod 17: 1826–32

    CAS  PubMed  Google Scholar 

  • Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554

    PubMed  Google Scholar 

  • Madersbacher S, Berger I, Ponholzer A, Marszalek M (2008) Plant extracts: sense or nonsense? Curr Opin Urol 18:16–20

    PubMed  Google Scholar 

  • Mahmoud AM, Goemaere S, El-Garem Y, Van Pottelberg Y, Comhaire FH, Kaufman JM (2003) Testicular volume in relation to hormonal indices of gonadal function in community-dwelling elderly men. J Clin Endocrinol Metab 88:179–184

    CAS  PubMed  Google Scholar 

  • Mariotti S (2002) Ageing and thyroid diseases. In Wass JAH, Shalet SM (eds) Oxford Textbook of Endocrinology and Diabetes. Oxford University Press, Oxford, pp 1425–1422

    Google Scholar 

  • McVary KT (2006) BPH: epidemiology and comorbidities. Am J Manag Care 12:122–128

    Google Scholar 

  • Meier C, Nguyen TV, Handelsman DJ, Schindler C, Kushnir MM, Rockwood AL, Meikle AW, Center JR, Eisman JA, Seibel MJ (2008). Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 14:47–54

    Google Scholar 

  • Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G (1999) Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286:774–779

    CAS  PubMed  Google Scholar 

  • Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R, Maggio M, Valenti G, Ceresini G (2007) Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Invest 28:101–104

    Google Scholar 

  • Morley JE, Kaiser FE, Johnson LE (1990) Male sexual function. In: Cassel CK, Riesenberg DE, Sorensen LB, Walsh JR (eds) Geriatric medicine, second edition. Springer, Berlin Heidelberg New York Tokyo, pp 256–270

    Google Scholar 

  • von Mühlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R (2008) Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos Int 19:699–670

    Google Scholar 

  • Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT (2005) Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 90:2618–2623

    CAS  PubMed  Google Scholar 

  • Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C (2006) Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 60:762–769

    CAS  PubMed  Google Scholar 

  • Neaves WB, Johnson L, Porter JC, Parker CR, Petty CS (1985) Leydig cell numbers, daily sperm production, and serum gonadotropin-levels in aging men. J Clin Endocrinol Metab 59:756–763

    Google Scholar 

  • Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR (2008) Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. Prostate 68:1477–1486

    PubMed  Google Scholar 

  • Nieschlag E, Michel E (1986) Reproductive functions in grandfathers. In: Mastroianni L, Paulsen CA (eds) Aging, reproduction, and the climateric. Plenum Publishing Corporation, New York, pp 59–71

    Google Scholar 

  • Nieschlag E, Lammers U, Freischem CW, Langer K, Wickings EJ (1982) Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab 55:676–681

    CAS  PubMed  Google Scholar 

  • Nieschlag E, Brinkworth M, Rolf C, Lerchl A (2000) Fertility and fertility related problems in the ageing male. Proceedings of the 9th International Menopause Society, World Congress of the Menopause, Parthenon, London

    Google Scholar 

  • Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 28:125–127

    CAS  PubMed  Google Scholar 

  • Nybo Andersen AM, Hansen KD, Andersen PK, Davey Smith G (2004) Advanced paternal age and risk of fetal death: a cohort study. Am J Epidemiol 160:1214–1222

    PubMed  Google Scholar 

  • Pope HG, Jr, Cohane GH, Kanayama G, Siegel AJ, Hudson JI (2003) Testosterone gel supplementation for men with refractory depression: A randomized, placebo-controlled trial. Am J Psychiatry 160:105–111

    PubMed  Google Scholar 

  • Quinn M, Babb P (2002) Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 90:162–173

    CAS  PubMed  Google Scholar 

  • Reid IR, Wattie DJ, Evans MC, Stapleton JP (1996) Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156:1173–1177

    CAS  PubMed  Google Scholar 

  • de la Rochebrochard E, Thonneau P (2002) Paternal age and maternal age are risk factors for miscarriage; rersults of a multicentre European study. Hum Reprod 17:1649–1656

    PubMed  Google Scholar 

  • Rolf C, Nieschlag E (1998) Potential adverse effects of long-term testosterone therapy. Baillières Clin Endocrinol Metab 12:521–534

    CAS  PubMed  Google Scholar 

  • Rolf C, Behre HM, Nieschlag E (1996) Reproductive parameters of older compared to younger men of infertile couples. Int J Androl 19:135–142

    CAS  PubMed  Google Scholar 

  • Rolf C, Kenkel S, Nieschlag E (2002a) Age-related diesease pattern in infertile men: increasing incidence of infections in older patients. Andrologia 34:209–217

    CAS  PubMed  Google Scholar 

  • Rolf C, von Eckardstein S, Koken U, Nieschlag E (2002b) Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study. Eur J Endocrinol 146:505–511

    CAS  PubMed  Google Scholar 

  • Rudman D, Feller AG, Nagraj HS, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1–6

    CAS  PubMed  Google Scholar 

  • Sartorius G, Nieschlag E (2009) Paternal age and reproduction. Hum Reprod Update (in press)

    Google Scholar 

  • Schlüter D (1978) Die endokrinen Organe der Über-Neunzigjährigen. Dissertation Universität Hamburg

    Google Scholar 

  • Seidman SN, Araujo AB, Roose SP, McKinlay JB (2001) Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 50:371–376

    CAS  PubMed  Google Scholar 

  • Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR (2006) Low serum testosterone and mortality in male veterans. Arch Intern Med 166:1660–1665

    CAS  PubMed  Google Scholar 

  • Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C (1997) Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82:1661–1667

    CAS  PubMed  Google Scholar 

  • Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL (1999a) Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84:1966–1972

    CAS  PubMed  Google Scholar 

  • Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL (1999b) Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647–2653

    CAS  PubMed  Google Scholar 

  • Statistische Jahrbücher 1980–2007 für die Bundesrepublik Deutschland. Statistisches Bundesamt Wiesbaden (Hrsg) Metzler Poeschel Verlag, Stuttgart

    Google Scholar 

  • Suzuki K, Ito K, Ichinose Y, Kurokawa K, Suzuki T, Imai K, Yamanaka H, Honma S (1995) Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration. Scand J Urol Nephrol 29:65–68

    CAS  PubMed  Google Scholar 

  • Swerdlow AJ (2006) Does growth hormone therapy increase the risk of cancer? Nat Clin Pract Endocrinol Metab 2:530–531

    PubMed  Google Scholar 

  • Tarin JJ, Brines J, Cano A (1998) Long-term effects of delayed parenthood. Hum Reprod 13:2371–2376

    CAS  PubMed  Google Scholar 

  • Tenover JS (1994) Androgen administration to aging men. Endocrinol Metab Clin North Am 23:878–892

    Google Scholar 

  • Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224

    CAS  PubMed  Google Scholar 

  • Tivesten A, Mellström D, Jutberger H, Fagerberg B, Lernfelt B, Orwoll E, Karlsson MK, Ljunggren O, Ohlsson C (2007) Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. J Am Coll Cardiol 50:1070–1076

    CAS  PubMed  Google Scholar 

  • Umbreit K (1993) Ist eine Substitution mit Estradiol auch bei Männern angezeigt? Gyne 14:56–60

    Google Scholar 

  • Valtonen M, Niskanen L, Kangas AP, Koskinen T (2005) Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects. Nord J Psychiatry 59:217–221

    PubMed  Google Scholar 

  • Vance ML (2003) Can growth hormone prevent aging? N Engl J Med 348:779–780

    PubMed  Google Scholar 

  • Vance ML, Mauras N (1999) Growth hormone therapy in adults and children. N Engl J Med 341:1206–1216

    CAS  PubMed  Google Scholar 

  • Veldhuis DJ, Keenan DM, Iranmanesh A (2005) Mechanisms of ensemble failure of the male gonadal axis in aging. J Endocrinol Invest 28 (Suppl 3):8–13

    CAS  PubMed  Google Scholar 

  • Vermeulen A, Kaufman JM (1995) Ageing of the hypothalamo-pituitary-testicular axis in men. Horm Res 43:2528

    Google Scholar 

  • Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, Steiner B, Hull L, Callegari C, Swerdloff RS (1996). Testosterone replacement therapy improves mood in hypogonadal men — a clinical research center study. J Clin Endocrinol Metab 81:3578–3583

    CAS  PubMed  Google Scholar 

  • Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC (2008) ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Eur J Endocrinol 159:507–514

    CAS  PubMed  Google Scholar 

  • Webb CM, Elkington AG, Kraidly MM, Keenan N, Pennell DJ, Collins P (2008) Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease. Am J Cardiol 101:618–624

    CAS  PubMed  Google Scholar 

  • Woodhouse LJ, Gupta N, Bhasin M, Singh AB, Ross R, Phillips J, Bhasin S (2004) Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 89:718–726

    CAS  PubMed  Google Scholar 

  • Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O’Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vaderschueren D, European Male Aging Study Group (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93:2737–2745

    CAS  PubMed  Google Scholar 

  • Zitzmann M (2006) Testosterone and the brain. Aging Male 9: 195–199

    CAS  PubMed  Google Scholar 

  • Zitzmann M (2007) Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men. Nat Clin Pract Uro 4: 161–166

    CAS  Google Scholar 

  • Zitzmann M, Nieschlag E (2003) Der Altershypogonadismus des Mannes, rationale Diagnostik und Therapie. Internist 10: 1313–1321

    Google Scholar 

  • Zitzmann M, Nieschlag E (2007) Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 92:3844–3853

    CAS  PubMed  Google Scholar 

  • Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E (2003) Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study. J Clin Endocrinol Metab 88:2049–2054

    CAS  PubMed  Google Scholar 

  • Zitzmann M, Faber S, Nieschlag E (2006) Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91:4335–4343

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St. Josef Hospital, Wiener Str. 1, 27568, Bremerhaven

    Dr. med. Claus Rolf

  2. Centrum für Reproduktionsmedizin und Andrologie, Universitätsklinikum Münster, Domagkstr. 11, 48149, Münster

    Prof. Dr. med. Michael Zitzmann & Prof. Dr. med. Dr. h.c. Eberhard Nieschlag

Authors
  1. Dr. med. Claus Rolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Michael Zitzmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. med. Dr. h.c. Eberhard Nieschlag
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Centrum für Reproduktionsmedizin und Andrologie, Universitätsklinikum Münster, Domagkstr. 11, 48149, Münster

    Eberhard Nieschlag  & Susan Nieschlag M.A.  & 

  2. Zentrum für Reproduktionsmedizin und Andrologie, Universitätsklinikum Halle (Saale), Ernst-Grube-Str.40, 06120, Halle

    Hermann M. Behre

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Rolf, C., Zitzmann, M., Nieschlag, E. (2009). Seneszenz und Altershypogonadismus. In: Nieschlag, E., Behre, H.M., Nieschlag, S. (eds) Andrologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-92963-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-92963-5_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-92962-8

  • Online ISBN: 978-3-540-92963-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation